"10.1371_journal.pone.0094794","plos one","2014-04-14T00:00:00Z","Federico Serana; Luisa Imberti; Maria Pia Amato; Giancarlo Comi; Claudio Gasperini; Angelo Ghezzi; Vittorio Martinelli; Leandro Provinciali; Maria Rosa Rottoli; Stefano Sotgiu; Sergio Stecchi; Michele Vecchio; Mauro Zaffaroni; Cinzia Cordioli; Ruggero Capra","CREA, Diagnostics Department, Spedali Civili of Brescia, Brescia, Italy; Department NEUROFARBA, Neuroscience Section, University of Florence, Florence, Italy; Department of Neurology, San Raffaele Scientific Institute, Milan, Italy; Multiple Sclerosis Center, S. Camillo-Forlanini Hospital, Rome, Italy; Multiple Sclerosis Center, Gallarate Hospital, Gallarate, Italy; Neurological Clinic, Ospedali Riuniti of Ancona, Ancona, Italy; Multiple Sclerosis Center, Papa Giovanni XXIII Hospital, Bergamo, Italy; Department of Clinical and Experimental Medicine, University of Sassari, Sassari, Italy; UOSI Riabilitazione Sclerosi Multipla, IRCCS Istituto delle Scienze Neurologiche of Bologna, Bologna, Italy; Multiple Sclerosis Center, St. Elia Hospital, Caltanissetta, Italy; Multiple Sclerosis Center, Spedali Civili of Brescia, Brescia, Italy","Conceived and designed the experiments: LI RC FS. Performed the experiments: LI FS. Analyzed the data: FS RC LI CC. Contributed reagents/materials/analysis tools: LI MA GC CG AG VM LP MR S. Sotgiu S. Stecchi MV MZ RC CC. Wrote the paper: FS LI RC. Validated EDSS calculations: CC.","The authors have read the journal's policy and declare the following conflicts: Federico Serana: received support to cover travel expenses and participation to congresses from Biogen-Idec, Merck-Serono, TEVA. Luisa Imberti: received support to cover travel expenses and participation to congresses from Biogen-Idec, Merck-Serono, TEVA, and grants from Biogen-Idec and Merck-Serono. Maria Pia Amato: has served as member of advisory boards, has received research grants, travel grants and honoraria for speaking and participation at meetings from Bayer, Biogen-Idec, Novartis, Merk-Serono, Teva, Sanofi Genzyme, Almirall. Giancarlo Comi: has received compensation for consulting services and/or speaking activities from Biogen-Idec, Novartis, Teva, Sanofi, Genzyme, Merck-Serono, Bayer, Serono Symposia International Foundation, Actelion and Almirall. Angelo Ghezzi: received honoraria for speaking from Bayer-Schering, Biogen-Idec, Merck-Serono, Novartis, Genzyme, Allergan, for consultancy from Biogen-Idec, Merck-Serono, Teva and Novartis, received support for participation to National and International Congresses from Bayer-Schering, Biogen-Idec, Merck-Serono, Novartis, Genzyme. Vittorio Martinelli: was a board member for Merck-Serono. He received travel grants and honoraria for travel expenses and for participation to Congresses from Biogen-Domp√© SG, Merck-Serono, Bayer Schering Pharma, Novartis, Teva Pharmaceutical Industries and Sanofi-Aventis. Maria Rosa Rottoli: receieved grants from Biogen-Idec, Novartis, Bayer. Mauro Zaffaroni: received honoraria for consultancy, participation in advisory boards or travel grants from Genzyme, Biogen Idec, Merck Serono, Sanofi Aventis, Teva, Novartis. Ruggero Capra: receieved speaking honoraria from Biogen-Idec, Bayer, TEVA, Genzyme, Novartis and Sanofi Aventis, and was a Steering Committee Member for Novartis e Biogen-Idec. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.","2014","04","Federico Serana","FS",15,TRUE,3,2,4,3,TRUE,TRUE,TRUE,2,"12;13",TRUE
